Primary Author Characteristics Associated With Publication in the Journal of Pain and Symptom Management.

J Pain Symptom Manage

Department of Medicine (M.C.S., K.T.M., J.S.K., K.L.C.), University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA; Adult and Child Center for Outcomes Research and Delivery Science (R.G.), Aurora, CO 80045, USA. Electronic address:

Published: February 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Context: Scientific journals are the primary source for dissemination of research findings, and this process relies on rigorous editorial and peer-review. As part of continuing efforts by the Journal of Pain and Symptom Management (JPSM) to advance equity, diversity, and inclusion, JPSM's leadership requested an external evaluation of their publication decisions.

Objectives: 1) Describe primary author characteristics associated with final decisions to accept or reject manuscripts submitted for publication; 2) Report on whether there are potential publication biases in the JPSM editorial or peer-review processes.

Methods: Data consisted of self-reported primary author demographic characteristics associated with manuscript submissions between June 18, 2020, and December 31, 2022. Characteristics included region of residence, race, gender, and ethnicity. A multiple logistic regression model was used to estimate adjusted odds of rejection for each author characteristic.

Results: A total of 1940 submissions were evaluated. Compared to authors residing in North America, authors residing in Asia had six-fold greater odds of rejection, authors residing in Europe had four-fold greater odds of rejection, and authors residing in other regions had two-fold greater odds of rejection. Female authors submitted 1.7 times more papers than males, but there was no difference in acceptance rates of their papers in adjusted analysis.

Conclusion: In this analysis of publication decisions by the JPSM, there were differences in acceptance rates by region of residence, ethnicity, and race but not by gender. Asian authors and authors residing in regions outside of North America had greater odds of rejection compared to White or North American authors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2023.10.014DOI Listing

Publication Analysis

Top Keywords

odds rejection
20
authors residing
20
greater odds
16
primary author
12
characteristics associated
12
author characteristics
8
journal pain
8
pain symptom
8
symptom management
8
editorial peer-review
8

Similar Publications

Background: Delayed graft function is a common situation that leads to increased long-term rates of graft rejection and loss. It is seen increasingly more often, as the use of kidneys from donors after controlled cardiac death has become more widespread. This study aimed to identify factors contributing to its onset and determine how these factors may influence graft survival.

View Article and Find Full Text PDF

Depression outcomes correlated to exposure to per- and poly-fluoroalkyl substances (PFAS).

Environ Sci Pollut Res Int

September 2025

Data Forward Analytics, LLC, Principal, Las Cruces, NM, 88011, USA.

Per- and poly-fluoroalkyl substances (PFAS) are fluorinated organic compounds known as forever chemicals that are used in many materials, from cooking appliances to industrial detergents. Given their high chemical stability due to their lipophilic properties and widespread use, PFAS tend to bioaccumulate in the cardiac, hepatic, renal, gastrointestinal, and neural tissues, resulting in a variety of malignant and non-malignant diseases. Depression is a prevalent mental health condition that affects an individual's activities of daily living.

View Article and Find Full Text PDF

Background: Omega-3 polyunsaturated fatty acids are known for anti-inflammatory and cardiovascular benefits, but their impact on solid organ transplant outcomes is unclear.

Objectives: To assess the effects of omega-3 supplementation on clinical outcomes in solid organ transplant recipients.

Methods: A systematic review and meta-analysis of randomized controlled trials was conducted according to PRISMA guidelines.

View Article and Find Full Text PDF

Corneal transplantation wound dehiscence after penetrating keratoplasty and deep anterior lamellar keratoplasty.

Int Ophthalmol

September 2025

Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, 200 Hawkins Dr, 11290A PFP, Iowa City, IA, 52242, USA.

Purpose: To study clinical characteristics and outcomes of penetrating keratoplasty (PK) and deep anterior lamellar keratoplasty (DALK) wound dehiscence.

Methods: This retrospective case series assessed PK and DALK recipients with wound dehiscence at a single institution. We evaluated relationships between dehiscence etiologies, transplant indications, ocular/systemic comorbidities, keratoplasty type, and adverse post-dehiscence outcomes, especially graft failure and visual loss.

View Article and Find Full Text PDF

A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System(FAERS) Event for Belatacept.

Transplant Proc

August 2025

Department of Urology/ Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, Chi

Objective: This study aims to comprehensively evaluate the safety profile of belatacept administration in real-world clinical settings.

Methods: Disproportionality analysis methodologies, including Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Multi-Item Gamma Poisson Shrinker (MGPS) algorithms, were utilized to quantify real-world adverse event (AE) signals associated with belatacept.

Results: A total of 4631 adverse event reports were extracted from the FDA Adverse Event Reporting System (FAERS) database, of which 2337 adverse events were identified as "primary suspect" (PS) attributed to belatacept.

View Article and Find Full Text PDF